相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
Timothy D. Gauntner et al.
TRANSPLANTATION AND CELLULAR THERAPY (2022)
Impact of infused CD34+stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide
Elmariah Hany et al.
BONE MARROW TRANSPLANTATION (2021)
Impact of CD34+cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation
Maria Queralt Salas et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2020)
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes?
Luciana Teofili et al.
CYTOTHERAPY (2020)
Evaluation and management of measurable residual disease in acute lymphoblastic leukemia
Iman Abou Dalle et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2020)
CD34+cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT)
Enrico Maffini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Impact of detectable measurable residual disease on umbilical cord blood transplantation
Frederic Baron et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Different Effects of Pre-transplantation Measurable Residual Disease on Outcomes According to Transplant Modality in Patients With Philadelphia Chromosome Positive ALL
Si-Qi Li et al.
FRONTIERS IN ONCOLOGY (2020)
Haploidentical Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Relapsed/Refractory Severe Aplastic Anemia
Leonardo Javier Arcuri et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia
Renato Bassan et al.
HAEMATOLOGICA (2019)
Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation
Sagar S. Patel et al.
BONE MARROW TRANSPLANTATION (2019)
Minimal residual disease status determined by multiparametric flow cytometry pretransplantation predicts the outcome of patients with ALL receiving unmanipulated haploidentical allografts
Xiao-Su Zhao et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Comparative Analysis of Flow Cytometry and RQ-PCR for the Detection of Minimal Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Hematopoietic Stem Cell Transplantation
Xiangyu Zhao et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia: Effects of CD34+ and CD14+ Cell Doses
Le-Qing Cao et al.
CHINESE MEDICAL JOURNAL (2018)
Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation
Monika Brueggemann et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2017)
Higher dose of CD34+peripheral blood stem cells is associated with better survival after haploidentical stem cell transplantation in pediatric patients
Yao Chen et al.
CLINICAL TRANSPLANTATION (2017)
Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study
Yu Wang et al.
CLINICAL CANCER RESEARCH (2016)
The impact of pre-transplant minimal residual disease on outcome of intensified myeloablative cord blood transplant for acute myeloid leukemia in first or second complete remission
Changcheng Zheng et al.
LEUKEMIA & LYMPHOMA (2016)
Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
Mats Remberger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
A prospective investigation of cell dose in single-unit umbilical cord blood transplantation for adults with high-risk hematologic malignancies
U. Sobol et al.
BONE MARROW TRANSPLANTATION (2015)
Low CD34 Dose Is Associated with Poor Survival after Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia and Myelodygplastic Syndrome
Johan Torlen et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
No Impact of Total or Myeloid Cd34+Cell Numbers on Neutrophil Engraftment and Transplantation-Related Mortality after Allogeneic Pediatric Bone Marrow Transplantation
Herbert Pichler et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation
Xiao-Su Zhao et al.
ANNALS OF HEMATOLOGY (2012)
Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
Nicola Goekbuget et al.
BLOOD (2012)
Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia
Bin Zhang et al.
CANCER CELL (2012)
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
T. Kalina et al.
LEUKEMIA (2012)
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
J. J. M. van Dongen et al.
LEUKEMIA (2012)
The Impact of Graft Composition on Clinical Outcomes in Pediatric Patients Undergoing Unmanipulated HLA-Mismatched/Haploidentical Hematopoietic Stem Cell Transplantation
Dai-Hong Liu et al.
PEDIATRIC BLOOD & CANCER (2011)
CD34+ cell dose and establishment of full donor chimerism at day+100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies
S. G. Holtan et al.
BONE MARROW TRANSPLANTATION (2010)
Platelet Engraftment in Patients with Hematologic Malignancies following Unmanipulated Haploidentical Blood and Marrow Transplantation: Effects of CD34+ Cell Dose and Disease Status
Ying-Jun Chang et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model
Xiaoxia Hu et al.
BLOOD (2009)
The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT
X-H Luo et al.
BONE MARROW TRANSPLANTATION (2009)
The Impact of CD34+ Cell Dose on Platelet Engraftment in Pediatric Patients Following Unmanipulated Haploidentical Blood and Marrow Transplantation
Ying-Jun Chang et al.
PEDIATRIC BLOOD & CANCER (2009)
Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells
Angela Colmone et al.
SCIENCE (2008)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
DP Lu et al.
BLOOD (2006)
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses
O Ringdén et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival
JE Wagner et al.
BLOOD (2002)
Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation
H Bittencourt et al.
BLOOD (2002)
A low CD34(+) cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34(+) cells/kg be considered the minimum threshold?
S Singhal et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
